The End of Stock Scarcity: SpaceX's Lockup Wave and the $1.5 Trillion Supply Shift
August 6 could be the most important day for market structure in 23 years — not because of earnings, but because of what unlocks.
For the better part of two decades, the defining structural feature of the US stock market was scarcity. S&P 500 companies retired nearly $12 trillion of their own shares through buybacks, shrinking the investable float year after year. Net equity issuance was negative — JPMorgan estimates roughly minus $430 billion between 2006 and 2025.[1] That era is ending, and August 2026 is where the rubber meets the road.
The signal came in June, when SpaceX priced the largest initial public offering in history: 555.6 million shares at $135 each, raising $75 billion at a valuation of approximately $1.77 trillion.[2] The stock opened at $150, briefly traded above $225, and then began a long slide back toward Earth. As of the July 31 close, SPCX sat at $108.37 — below its IPO price and down more than 50% from its first-day peak.[3]
But the IPO itself was the easy part. The hard part begins on August 6.
The Lockup Clock
Two days after SpaceX reports its first quarterly results as a public company on August 4, roughly $123 billion in shares — nearly one billion — begin unlocking from lockup restrictions.[4] Pre-IPO investors, employees, and other insiders who bought or held shares before the offering will become eligible to sell for the first time.[5]
The scale is without modern precedent. The $123 billion in unlockable shares dwarfs the $75 billion SpaceX raised in its IPO.[4] If even a fraction of those holders choose to monetize, the selling pressure on SPCX will be a real-time stress test of market absorption capacity — not for a mid-cap biotech, but for one of the largest companies in the world by market capitalization.
SpaceX is already trading below its IPO price, which means many pre-IPO holders are still sitting on substantial gains relative to their cost basis even as public-market buyers are underwater. That asymmetry — insiders with low cost bases facing public investors who bought near the top — is the classic lockup-expiry dynamic, magnified here by the sheer size of the float being released.
The $600 Billion Question
SpaceX’s lockup wave is the most dramatic instance of a broader pattern. Goldman Sachs Research estimates total US equity supply will reach approximately $600 billion in 2026, with roughly $160 billion tied directly to IPO activity.[6] The bank published its analysis under the headline “IPO Surge: A Red Flag for Markets?” on July 28, framing two key questions: whether the surge is a late-cycle warning sign, and whether the market can comfortably digest the volume.[7]
Goldman’s conclusion is conditional. Tony Pasquariello, the bank’s global head of hedge fund coverage, argued that $600 billion sounds alarming in nominal terms but is less extraordinary measured as a share of total market capitalization. Historical analogs — the late-1990s tech bubble, the 2009 post-crisis recapitalizations, the 2020 pandemic raise, the 2021 SPAC frenzy — each generated comparable supply waves relative to market size.[6] In each case, the outcome depended on the quality of what was being issued and the risk appetite of buyers.
The conditional is doing heavy lifting. Goldman also flagged that this supply wave arrives alongside elevated Treasury yields and historically concentrated positioning in AI-related semiconductors — hedge funds entered Q2 2026 with their highest-ever portfolio weight in semis at 10%.[6] Three forces converging simultaneously: rising supply, sticky yields, and crowded positioning. Any one is manageable. All three at once narrows the margin for error.
The Structural Shift
JPMorgan’s framing is starker. The bank forecasts that approximately $1.5 trillion of net new stock will be added to US equity markets over the next two years — even after accounting for continuing buybacks.[1] If realized, it would mark the strongest period of net equity issuance since at least the late 1990s and the first time in 23 years that the US stock market stops shrinking.[1]
The driver is valuation. With the S&P 500 trading near 25 times earnings — a level rarely exceeded this century — equity has become cheaper to issue than debt.[1] The cost-of-capital inversion that began when the Federal Reserve raised rates to a two-decade high in 2023 has persisted even as the Fed started cutting, because the $30 trillion share rally since the rate peak kept equity terms attractive.[1] Companies are rationally choosing to sell shares rather than borrow.
This is not a prediction of a crash. It is an observation about a regime change. For two decades, the marginal price-setting force in US equities was companies buying their own stock. The float shrank, and scarcity supported multiples. Going forward, the marginal force shifts to companies and insiders selling — expanding the float. The base rate question is whether demand grows fast enough to match the new supply at current valuations, or whether multiples need to adjust to clear the market.
What 2026 Looks Like in Numbers
Renaissance Capital counts 87 IPOs priced year-to-date through mid-July, a 26.9% decline in deal count from the same point in 2025 — but total proceeds of $142.5 billion, driven by a small number of very large deals.[8] Q2 alone saw 48 offerings, led by SpaceX’s $75 billion.[8] Nine other IPOs in the quarter raised $1 billion or more each.[8]
The deal count is down; the deal size is up. That concentration matters. When a handful of mega-IPOs dominate the calendar, the market’s ability to absorb supply becomes a function of how smoothly those specific names digest — not a broad-based issuance climate. SpaceX’s post-IPO trajectory, from $225 peak to $108.37 at last close,[3] is an early data point on how much demand actually exists at these valuations.
| Metric | YTD 2026 (through mid-July) | Context |
|---|---|---|
| IPOs priced | 87 | -26.9% vs. same period 2025[8] |
| Total proceeds | ~$142.5B | Driven by SpaceX’s $75B and 9 other $1B+ deals[8] |
| Total equity supply (est.) | ~$600B | Goldman forecast, including secondaries[6] |
| Net issuance forecast (2yr) | ~$1.5T | JPMorgan estimate, net of buybacks[1] |
| SPCX current price | $108.37 | Below $135 IPO price, -50%+ from peak[3] |
| SPCX lockup unlock | ~$123B | ~1B shares eligible Aug 6[4] |
The Pipeline Behind the Pipeline
The 2026 IPO calendar does not end with SpaceX. According to tracking from multiple sources, the pipeline includes:
- Anthropic: Filed confidentially in June, targeting an October 2026 listing at a valuation approaching $900 billion, with annualized revenue reportedly crossing $44 billion.[9] Goldman Sachs, JPMorgan, and Morgan Stanley are in discussion as lead underwriters.[9]
- OpenAI: Pre-filing, with CFO Sarah Friar signaling late 2026 or 2027 as the likely window.[9] The company’s conversion from nonprofit to a public benefit corporation adds timeline uncertainty.[9] At an $852 billion private valuation with $25 billion in annualized revenue, the IPO target is approximately $1 trillion.[9]
- Databricks: Profitable, with $5.4 billion in revenue growing 65% year-over-year and positive free cash flow. An H2 2026 S-1 filing is expected.[9]
- Stripe: No confirmed timeline. The Collison brothers have repeatedly stated an IPO is “a solution in search of a problem” given the company is self-funding and profitable.[9]
If Anthropic prices in October at the figures circulating, the second half of 2026 would see two of the three largest IPOs in history hit the market within five months. The cumulative supply from SpaceX, Anthropic, and the $1B+ cohort would push 2026 well past $200 billion in IPO proceeds alone.
Private Markets: Manufacturing Liquidity
The supply wave is not confined to the IPO window. The private-market secondary ecosystem has scaled to bridge the timing gap between private valuation marks and public-market exits.
Secondary market volumes reached $220 billion in 2025, another record year, with no signs of slowing in 2026.[10] Continuation funds — vehicles that allow private equity GPs to roll assets into a new fund rather than sell — have tripled in deal volume since 2021 and now account for approximately 14% of all private equity exits.[10] Skadden notes that high interest rates, valuation gaps, and demand for longer-term exposure to quality assets have driven the surge.[10]
One illustration of the discount reality: CT Private Equity Trust recently sold a portfolio of mature fund interests at a 16.1% discount to net asset value — a haircut that was actually smaller than the trust’s own share-price discount, making the transaction accretive in relative terms, but still real evidence that private marks and cash-clearing prices diverge.[11]
The structural point: private-market liquidity is increasingly being manufactured rather than assumed.[11] As the IPO window reopens unevenly — with some names pricing well and others struggling — the secondaries market is absorbing the overflow, but at discounts that reveal where the real clearing price sits.
Market-Structure Backdrop
On the plumbing side, Coalition Greenwich identifies the SEC’s lighter regulatory posture as a catalyst for continued equity market-structure innovation in 2026: review of the Order Protection Rule, exploration of tokenization and distributed ledgers, “innovation exemptions” for next-generation trading technologies, and the push toward 24/7 trading.[12]
The Greenwich team frames the tension plainly: while most participants can navigate without guardrails, “consequences are catastrophic for the one that drives a little too fast and goes over the cliff.”[12] The combination of lighter regulation, tokenized collateral, and expanded trading hours could increase liquidity-sourcing opportunities — but it also means the system is absorbing a historic supply wave with fewer circuit breakers than it had a decade ago.
GlobalFoundries offers a case study in the secondary/buyback interplay: the company launched a 20-million-share secondary offering at $42.00 per share alongside a $300 million share buyback from Mubadala, part of a broader $500 million repurchase program.[11] That simultaneous pattern — insiders selling while the company buys back — is becoming more visible as the supply tide turns. It is not inherently negative; the buyback partially offsets the dilution. But it does mean the net supply reduction that characterized the 2010s is no longer the default.
What to Watch Next
-
August 4 — SpaceX earnings: The first quarterly report as a public company. Starlink subscriber growth and AI-related capex will be the focal points.[5] Revenue trajectory relative to the $1.77 trillion valuation will set expectations for the lockup cohort.
-
August 6 — Lockup expiry begins: ~$123 billion in SPCX shares become eligible for sale.[4] The speed and volume of insider selling — and SPCX’s price reaction — will be the most granular real-time data point on whether the market can absorb large-block supply at current valuations. Watch for whether selling is gradual or concentrated, and whether index funds that must hold SPCX at its market weight end up as the marginal buyers.
-
September–October — Anthropic IPO process: If Anthropic’s S-1 goes public and the roadshow begins, the deal size and indicated valuation will signal whether the IPO window is still open for mega-cap AI or whether SpaceX’s post-IPO performance has narrowed appetite.[9]
-
Net issuance data: Watch Federal Reserve Z.1 flow-of-funds data and JPMorgan/Goldman supply trackers for whether the $1.5 trillion two-year projection[1] is tracking or undershooting. If net issuance disappoints — because deals are pulled or downsized — that is itself a signal about demand capacity.
-
Semiconductor positioning: Goldman’s flag on 10% hedge fund weight in semis[6] means that any disappointment in the AI narrative could amplify supply-driven selling. If IPO supply and AI de-grossing hit simultaneously, the marginal liquidity test becomes considerably harder.
The base case is that the market absorbs the supply — Goldman says it can, and the historical analogs support that when quality is high and risk appetite holds.[6] The risk case is that SpaceX’s lockup wave reveals thinner marginal demand than the IPO order book suggested, and that the Anthropic pricing encounters a less receptive market as a result. The probability I would assign to a smooth absorption is roughly 60/40 — the 60 being the base case where quality names clear at adjusted valuations and the 40 being a scenario where supply arrives faster than demand can reprice, creating a valuation air pocket that narrows the IPO window for the remainder of 2026 and into 2027.
August 6 is the first real data point. Everything that follows will be read through what happens that week.
Sources
- SpaceX and OpenAI Are Ending Wall Street’s Era of Stock Scarcity
- SpaceX - Space Exploration Technologies Corp. Announces Closing of Initial Public Offerin…
- Quote: SPCX
- Looming SpaceX lockup expiries open the door to avalanche of selling | IFR
- SpaceX Earnings Are Coming Aug. 4. Here's Why Aug. 6 Could Be Even More Important For Inv…
- investing.com/analysis/goldman-says-market-can-handle-600b-stock-supply-wave-but-timing-i…
- IPO Surge: A Red Flag for Markets?
- 2026 IPO Market Stats - Renaissance Capital
- IPO Timeline Tracker: OpenAI, Anthropic, Stripe & Databricks (Updated July 2026) - Alloca…
- 2026 Secondary Market Report
- The IPO Wave Is Historic. So Is Today's Market.
- Top market structure trends to watch in 2026 | Coalition Greenwich